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Abstract
Rationale There has recently been increasing interest in the
potential of flavanols, plant-derived compounds found in
foods such as fruit and vegetables, to ameliorate age-related
cognitive decline. Research suggests that cocoa flavanols im-
prove memory and learning, possibly as a result of their anti-
inflammatory and neuroprotective effects. These effects may
be mediated by increased cerebral blood flow (CBF), thus,
stimulating neuronal function.
Objectives The present study employed arterial spin labelling
functional magnetic resonance imaging to explore the effect of
a single acute dose of cocoa flavanols on regional CBF.
Methods CBF was measured pre- and post-consumption of
low (23 mg) or high (494 mg) 330 ml equicaloric flavanol
drinks matched for caffeine, theobromine, taste and appear-
ance according to a randomized counterbalanced crossover
double-blind design in eight males and ten females, aged
50–65 years. Changes in perfusion from pre- to post-
consumption were calculated as a function of each drink.
Results Significant increases in regional perfusion across the
brain were observed following consumption of the high
flavanol drink relative to the low flavanol drink, particularly
in the anterior cingulate cortex and the central opercular cortex
of the parietal lobe.
Conclusions Consumption of cocoa flavanol improves re-
gional cerebral perfusion in older adults. This provides evi-
dence for a possible acute mechanism by which cocoa
flavanols are associated with benefits for cognitive
performance.
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Introduction
In recent years, there has been a great deal of interest in the
neuroprotective effects of flavonoids, with evidence emerging
that they may lead to improvements in memory and learning
by improving neuronal functioning and promoting neuronal
protection and regeneration (Spencer 2009). One sub-class of
flavonoids which has attracted interest in this respect are
flavanols. Dietary intervention trials have shown that con-
sumption of flavanol-containing cocoa products are associated
with a range of health benefits such as reduced platelet aggre-
gation (Holt et al. 2002), improved insulin sensitivity (Grassi
et al. 2005) and reduced blood pressure (Taubert et al. 2007).
Further to the aforementioned memory and learning ef-
fects, randomised placebo-controlled trials indicate that daily
consumption of flavanol-rich cocoa drinks over 8 weeks is
associated with improved cognitive function in healthy older
adults (Mastroiacovo et al. 2015) and older adults with mild
cognitive impairment (Desideri et al. 2012). Human trials
have predominately revealed that tests of executive function
and processing are sensitive to cocoa flavanols (see Scholey
and Owen 2013, for a review).More specifically, cocoa drinks
containing 990 and 520 mg flavanols were associated with
benefits for executive function and processing speed relative
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to a 48-mg flavanol cocoa drink. Furthermore, there is evi-
dence that a single dose of cocoa flavanols can also confer
positive cognitive effects in the immediate post-prandial peri-
od, even in healthy young populations. For example, Field
et al. (2011) observed better spatial working memory and
choice reaction time 2 h following consumption of dark
chocolate containing 773 mg flavanols relative to a white
chocolate control, whilst Scholey et al. (2010) observed im-
provements in executive function 1 h after consumption of
990 or 520 mg cocoa flavanols relative to a 46-mg control.
Interestingly, positive effects for mood were also reported,
such that self- reported increases in mental fatigue over the
morning were attenuated by the 520 mg flavanol drink. Sim-
ilar benefits for subjective mood in the form of increased
calmness and contentedness have also been observed follow-
ing 30 days of daily consumption of 550 mg cocoa flavanols,
although no behavioural effects were reported (Pase et al.
2013).
The evidence suggests that consumption of flavanol-rich
cocoa is associated with observable improvements in behav-
ioural outcomes. It has been postulated that vascular effects
form the basis of the mechanisms by which flavanol ingestion
may lead to benefits for neuronal and cognitive function
(Spencer 2009). For example, there is evidence of sub-
chronic and acute increases in peripheral blood flow following
ingestion of cocoa (Faridi et al. 2008), which may translate to
increased cerebral blood flow (CBF). Francis et al. (2006)
observed an increase in CBF (increased global perfusion in
grey matter) using arterial spin labelling (ASL) in a pilot
study of four healthy young females following consumption
of a 516-mg cocoa flavanol drink relative to a 39-mg
flavanol cocoa drink, which peaked approximately 2 h after
consumption. Interestingly, in a separate sample of 16
healthy young females, an increase in the blood oxygenation
level-dependent (BOLD) signal (measured with functional
magnetic resonance imaging (fMRI)) was observed in vari-
ous brain regions during performance of an attention
switching task following daily consumption of 172 mg co-
coa flavanols relative to 13 mg over 5 days using a parallel
groups design (Francis et al. 2006). However, there was no
evidence that the changes in the BOLD signal were associ-
ated with cognitive benefits since the performance on the
attention switching task was not different between the high
and low flavanol conditions. Similarly, Camfield et al.
(2012) reported regional amplitude modulations in steady-
state visually evoked potentials measured with Steady State
Probe Topography during memory encoding in a spatial
working memory task following 30 days, daily consumption
of 250 and 500 mg cocoa flavanol drinks relative to a low
flavanol placebo. Whilst no behavioural effects on the spa-
tial working memory task were observed, the authors sug-
gested that the observed amplitude modulations indicate
more efficient task performance.
More recently, promising data has emerged showing a cou-
pling between cerebral physiology and cognitive benefits
following cocoa flavanol consumption. Brickman et al.
(2014) observed increased cerebral blood volume (CBV) in
a sub-region of the hippocampus (dentate gyrus) as measured
with fMRI following ingestion of a daily 900 mg flavanol
supplement (n=21) over 3 months relative to a 45-mg flavanol
supplement (n=20) in healthy older adults (aged 50–69). Cru-
cially, significantly faster pattern recognition was observed
during the fMRI assessment for the high flavanol intervention
relative to the low flavanol intervention (with baseline perfor-
mance included as a covariate). Moreover, the positive corre-
lation between CBV and faster reaction time indicates that
increases in CBF in the hippocampus might also be associated
with behavioural benefits on hippocampal-dependent memory
tasks.
Whilst there is some evidence to support benefits for CBF
following chronic cocoa flavanol consumption, only one
study has investigated acute effects within the immediate post-
prandial period (Francis et al. 2006) which is a small pilot
study (n=4) that only reports changes in global CBF.
Brickman et al. (2014) provide evidence for regional perfu-
sion benefits following chronic (3-month) ingestion of cocoa
flavanols; therefore, it is of interest to examine whether re-
gional effects are also observed following acute cocoa
flavanol administration, particularly, given that behavioural
benefits have been documented within this timeframe (e.g.
Scholey et al. 2010; Field et al. 2011). Following from this,
the aim of the present study was to investigate perfusion on a
regional basis in the human brain with ASL in the acute post-
prandial period following cocoa flavanol consumption.
Materials and methods
Participants
Eighteen (10 males) native English-speaking healthy older
adults aged 55–65 years (mean age 61 years) without neuro-
logical symptoms were recruited from the local community.
Exclusion criteria included obesity (>30 kg/m2), current or
recent illness, diagnosed diabetes, diagnosed cardiovascular
disease, diagnosed hypertension, history of stroke, chronic
consumption of medication, gall bladder/gastrointestinal ab-
normalities, high habitual consumption of alcohol (15 units/
week), consumption of illegal substances, evidence of demen-
tia (Mini-Mental State Examination; MMSE <26), language
or hearing impediments and allergy or sensitivity to chocolate,
dairy, nuts or gluten. Inclusion/exclusion criteria were
checked during a screening session with a standard medical
questionnaire. The study was conducted according to the
guidelines of the Declaration of Helsinki, and all procedures
involving human subjects were approved by the University of
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Reading Research Ethics committee. All participants provided
written informed consent at the screening visit.
Design
A 2×2 randomised counterbalanced crossover double-blind
design was employed with two conditions, low flavanol
(LF) and high flavanol (HF), and two time points, baseline
and 2 h. An independent researcher generated a random allo-
cation sequence (using restricted randomisation) and allocated
participants into their groups. The order of drink consumption
was counterbalanced such that nine participants consumed the
LF at visit one and nine consumed the HF at visit one. The
alternate drink was consumed at visit two following a 1-week
washout.
Drinks
The 330-ml intervention drinks were provided byMars Incor-
porated (Hackettstown, NJ, USA) as dry, dairy-based cocoa
beverage mixes. The low and high flavanol drinks contained
23 and 494 mg total flavanols, respectively (see Table 1). The
amount of total cocoa flavanols referenced here is defined as
the sum of all monomeric flavanols and their oligomeric de-
rivatives (dimers to decamers, i.e. 2–10 monomeric subunits).
Both drinks were equicaloric (113 kcal) and matched for mac-
ronutrients, micronutrients, theobromine (HF, 185 mg; LF,
177 mg) and caffeine (HF, 15 mg; LF, 17 mg). The LF and
HF drinks were matched for taste and appearance by the man-
ufacturers and were supplied in individual sachets labelled
with an anonymous three-digit code; thus, all experimenters
and participants remained blinded during the procedures and
analysis. The code was broken following completion of the
analysis.
Procedure
Initially, telephone screening interviews were performed and
volunteers who met the inclusion criteria were invited to at-
tend the Centre for Integrative Neuroscience and
Neurodynamics (CINN) for a screening visit. At the screening
visit, inclusion/exclusion criteria were checked with the
MMSE and a standard medical questionnaire, and informed
consent was obtained following a description of the study
procedures. Each test visit was identical. Participants arrived
at 8 a.m. having fasted from 8 p.m. the previous night (water
consumption was permitted). Prior to each test day visit, par-
ticipants were also instructed to avoid vigorous physical ac-
tivity and polyphenol-rich foods for 24 h (including berries,
fruits, fruit juices, jams and preserves, red wine, black, green
and fruit teas, coffee, cocoa, soy products, caffeinated energy
drinks and vegetables, except potatoes) and were provided
with standardised typed instructions identifying which foods
to avoid. Upon arrival, a standardized breakfast of croissants
and low fat cream cheese was consumed (24.5 g fat, 10.1 g
protein, 38.4 g carbohydrates and 415 kcal). Following break-
fast, participants completed an initial 12-min scan including
structural and ASL sequences detailed below. For each scan,
participants were instructed to close their eyes without
sleeping and to remain as still as possible. Upon completion
of the scan, participants consumed the 330-ml-cocoa bever-
age. Two hours post-ingestion, a second 12-min scan was
Table 1 Composition of high
flavanol and low flavanol cocoa
drinks
Component High cocoa flavanol drink (HF) Low cocoa flavanol drink (LF)
Packet size, g 30 30
Cocoa flavanols (DP 1–10), mg 494 29
Epicatechin, mg 89 3
Catechin, mg 21 3
Dimers–decamers, mg 384 20
Calories 113 112
Total fat, g 1 1
Saturated fat, g 1 1
Cholesterol, mg 5 5
Sodium, mg 197 204
Total carbohydrates, g 16 16
Dietary fiber, g 3 4
Sugars, g 10 9
Protein, g 9 9
Caffeine, mg 15 17
Theobromine, mg 185 176
Potassium, mg 507 573
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completed. During the 2 h between scans, participants
remained within the CINN where they were permitted to read
and only consume water.
fMRI Protocol
Scanning was performed at the CINN, University of Reading,
UK using a 3.0 T Siemens MAGNETOM Trio MRI scanner
with a 12-channel Head Matrix coil. The pulsed ASL images
were acquired using the PICOREQ2T sequence with the fol-
lowing parameters: number of slices=18, slice thickness=
5.0 mm, inter-slice gap=1.25 mm, TR=2500 ms, TE=
11 ms, TI1=700, Saturation Stop Time=1,600, TI2=1,800
and perfusion mode=PICOREQ2T (pulsed). A high-
resolution whole-brain three-dimensional anatomical image
was also acquired using an MPRAGE-gradient sequence with
176×1 mm thick slices (1×1×1 voxels size; TE, 2.52 ms; TR,
2,020 ms; TI, 1,100 ms; FOV, 250×250; slice thickness,
2 mm; and flip angle, 9°). FMRI data processing was carried
out using FEAT (FMRI Expert Analysis Tool) Version 5.98,
part of FSL (FMRIB’s Software Library, www.fmrib.ox.ac.
uk/fsl). ASL volumes from each scanning session were all
registered to the corresponding individual’s high resolution
structural image using rigid body transformations. In a
second step, the images were registered to the Montreal
Neurological Institute (MNI) template brain using a 12° of
freedom affine transformation algorithm. To allow voxelwise
comparisons we processed each CBF map individually by
using perfusion signal modelling, which models the differ-
ences between control images and tagged (spin labelled) im-
ages within a time series.
Statistical analysis
It was hypothesised that there would be an increase in perfu-
sion between the two time points (baseline and 2 h) only for
the HF condition. This hypothesis was tested by contrasting
the two difference maps (i.e. perfusion as change from base-
line for the HF drink contrasted with perfusion as change from
baseline for the LF drink). In order to do, this a CBF map was
produced for each participant, time point (baseline and 2 h)
and drink (LF and HF). These perfusion flow maps were then
provided as inputs to the second level analyses which, sepa-
rately for each drink, processed the difference between the 2-h
post-drink and the pre-drink baseline. Specifically, these con-
trasts had the form of a simple subtraction defined as: CBF 2 h
−CBF baseline. The output of this second step was voxelwise
contrast images which corresponded to the change in the per-
fusion flow post-drink consumption. The second level con-
trast images were then entered in a third level analysis
consisting of a paired sample t test comparing the drink con-
ditions. Specifically, change in perfusion after the HF drink
was contrasted with change in perfusion after the LF drink.
The resulting Z (Gaussianised T/F) statistic image was then
cluster thresholded with initial clusters determined using a
voxelwise uncorrected height threshold of Z>2.3 followed
by a cluster significance threshold of p<0.05 (corrected for
multiple comparisons). Prior to analysis, normality checks
were performed on all data. Analyses were performed with
FSL v4.0.
Results
The HF–LF contrast analysis revealed significantly increased
regional perfusion 2 h post-consumption of the HF drink rel-
ative to the LF drink. As shown in Fig. 1, there are two main
clusters of voxels with significantly greater CBF at 2 h post-
consumption of the HF drink. The first cluster is in the anterior
cingulate cortex (ACC), with a sub-cluster slightly posterior
and superior to the main focus. The second cluster extends
from the central opercular cortex of the left parietal lobe down
to a sub-cluster in the temporal pole. The details of this, in-
cluding coordinates and cluster sizes, are given in Table 2.
Importantly, the reverse contrast, low flavanol–high flavanol,
produced no activation. The reverse contrast was performed
because significant activation would have been inconsistent
with the hypothesis.
Discussion
The present data provide evidence that consumption of cocoa
flavanols is associated with acute increases in regional CBF in
older adults as measured with ASL. More specifically, statis-
tically significant increased perfusion was observed in the
anterior cingulate cortex and regions of the parietal lobe 2 h
post-consumption of 494 mg cocoa flavanols in the form of a
drink relative to a calorie, caffeine and theobromine-matched
cocoa drink containing 23 mg flavanols. These findings are
consistent with the only previously published study of acute
effects of a single cocoa flavanol dose on blood flow in the
brain using ASL. Francis et al. (2006) demonstrated increased
global CBF 2 h post-consumption of 516 mg cocoa flavanols
in small sample of young adults. The present data extends
these findings by demonstrating increased perfusion in specif-
ic brain regions in older adults.
The present findings are also consistent with functional
imaging data showing regional specific increases in the
BOLD response to a task following daily consumption of
172 mg cocoa flavanols relative to 13 mg over 5 days (Francis
et al. 2006). More specifically, Francis et al. (2006) observed
increased BOLD response in the dorsolateral prefrontal cor-
tex, parietal cortex and ACC, whilst presently, increased per-
fusion was observed in the ACC and the central opercular
cortex of the left parietal lobe down to a sub-cluster in the
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temporal pole. In the study by Francis et al. (2006), partici-
pants performed an executive function task during the BOLD
assessment; therefore, the regions of activity assessed were
specifically associated with task switching. In contrast, the
present findings show increased perfusion during conscious
resting state. Despite the different natures of the two studies
(BOLD during task vs. ASL at rest), it is notable that there is
some regional overlap in the ACC between these two studies,
highlighting the particular sensitivity of the ACC to flavanol
ingestion. As part of the brain’s limbic system, the ACC plays
a role in environmental and task monitoring, distributing at-
tention and learning and is activated in a wide variety of cog-
nitive and emotional neuroimaging tasks (for the review, see
Bush et al. 2000).
As no task was performed in the current study, it is difficult
to make associations between the presently observed regions
of increased perfusion and previously demonstrated
behavioural effects. Following a single dose of cocoa, cogni-
tive improvements in the immediate postprandial period have
been shown for executive function (Scholey et al. 2010), spa-
tial memory and attention (Field et al. 2011), although inter-
pretations directly related to flavanols from the latter study are
limited due to a non-matched white chocolate control. To ad-
vance this field, direct associations between increased CBF/
activation and behavioural outcomes are required. Indeed,
Brickman et al. (2014) provide evidence for a direct associa-
tion between increased CBV in the dentate gyrus and im-
proved performance on a hippocampal-dependent pattern rec-
ognition task following 3 months daily cocoa flavanol con-
sumption. However, similar evidence following a single cocoa
dose is required. Other studies have failed to find simulta-
neous increases in CBF or neuronal activation and improved
cognitive performance. For example, Francis et al. (2006) re-
ported an increase in CBF during an attention switching task
Table 2 Stereotaxic coordinates (MNI template brain) and cluster sizes for brain areas where significantly greater change in blood perfusion occurred
following the high flavanol drink (494 mg) relative to the low flavanol drink (23 mg)
Brain region No. of voxels X Y Z Peak Z stat
Anterior cingulate 1,040 0 34 −4 3.9
Anterior cingulate (peak of sub-cluster) 0 12 28 3.5
Left parietal lobe: central opercular cortex 864 −44 −14 −4 3.8
Peak of sub-cluster: temporal pole −42 6 18 2.7
Fig. 1 Axial slices showing regions of significantly greater regional
perfusion 2 h post-consumption of the high flavanol drink relative to
the low flavanol drink using arterial spin labelling. Significantly greater
change in blood perfusion occurred following the high flavanol drink
compared to the low flavanol drink in two clusters; the ACC and the
central opercular cortex of the left parietal lobe down to a sub-cluster in
the temporal pole. Anatomical labels and coordinates are given in Table 2.
Activations are superimposed on axial slices of the MNI template brain.
The images were initially thresholded at Z>2.3 to identify activation
clusters and then a (corrected) cluster significance threshold of p<0.05
was applied (see the BMaterials and methods^ section)
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following 172 mg cocoa flavanols relative to 13 mg, but at-
tention switching performance was not affected. Similarly,
increased steady state evoked potentials (assessed using
Steady State Probe Topography) in posterior parietal and cen-
tral–frontal regions was observed in middle-aged adults fol-
lowing 30 days daily consumption of 250 or 500 mg cocoa
flavanol drinks relative to placebo; however, there were no
effects for behavioural measures of spatial working memory
(Camfield et al. 2012). Clearly, further studies are required
concomitantly examining CBF and neuronal activation with
behavioural cognitive measures following both long term and
acute consumption of cocoa flavanols.
The specific mechanisms underlying regional specific per-
fusion remain to be elucidated; however, there is now a grow-
ing body of evidence supporting a beneficial effect of cocoa
flavanols for peripheral (Schroeter et al. 2006) and cerebral
vascular function in humans. Flavanol-rich cocoa has been
shown to induce vasodilation via activation of the nitric oxide
system (Fisher et al. 2003), providing one plausible mecha-
nism for vascular benefits. Moreover, cocoa flavanols have
been associated with enhancement of several measures of en-
dothelial function and nitric oxide synthesis in animal (Karim
et al. 2000) and human models (Fisher et al. 2003; Heiss et al.
2003; Fisher and Hollenberg 2006). Recently, a meta-analysis
of the effects of cocoa on endothelial function reported a
pooled estimate increase of 2 % in a flow-mediated dilation
following cocoa consumption relative to placebo/control
(Petrone et al. 2013).
Interestingly, in one study, cocoa flavanol induced im-
provement in endothelial function was greatest in older adults
relative to younger adults (Fisher and Hollenberg 2006),
which raises the possibility that effects of cocoa flavanols on
CBF may vary as a function of age. Age mediated effects
could explain why Francis et al. (2006) observed increased
global perfusion in younger adults, whereas the present study
in older adults revealed increased regional perfusion; howev-
er, it should be acknowledged that the former study did not
analyse or report regional perfusion and therefore direct com-
parisons with the present data are limited. Nevertheless, future
research should investigate the effect of age since it may shed
light on underlying mechanisms. If increased vasodilation via
nitric oxide synthesis accounts for the vascular benefits (Fish-
er et al. 2003), then older adults with poorer endothelial func-
tion may be more likely than younger adults with efficient
endothelial function to benefit from cocoa flavanol consump-
tion. For example, populations including smokers (Heiss et al.
2005) and overweight adults (Faridi et al. 2008) have shown
improved endothelial vasodilation following cocoa flavanol
ingestion.
In order for cocoa flavanols and their metabolites to exert
effects on the brain, they would be expected to cross the blood
brain barrier (BBB; see Nehlig et al. 2012 for review). Rodent
models have demonstrated that epicatechin is found in the
brain following oral ingestion (Abd El Mohsen et al. 2002)
leading to increased dendritic spine density in the dentate gy-
rus (van Praag et al. 2007). Various flavonoid-binding sites on
neurons have now been described: adenosine (Agullo et al.
1997), GABAA (Johnston 2005; Fernandez et al. 2008), δ-
opioid (Katavic et al. 2007; Panneerselvam et al. 2010), nico-
tinic (Lee et al. 2010; Lee et al. 2011), TrkB (Jang et al. 2010),
estrogen (Jacobson et al. 2002) and testosterone receptors
(Bastianetto et al. 2010) and, more generally, a specific brain
plasma membrane binding site for polyphenols has been pro-
posed (Goyarzu et al. 2004). At present, it is unclear which, if
any, of these receptors is responsible for mediating flavanol-
induced stimulation of neuronal activity which could account
for increased blood flow in specific regions (Miller et al. 2001;
Wang et al. 2003; Tjandra et al. 2005), and furthermore, it is
difficult to establish cause and effect between increased neu-
ronal activity and increased regional specific blood flow.
However, receptor-binding flavanols and their metabolites
will trigger the activation of various downstream kinases, in-
cluding various members of both the MAP kinase and PI3
kinase pathways, and as well as inducing the opening of
agonist-activated ion channels leading to increased activity
(Luh et al. 2000; Kim and Duong 2002). Further work is
required in order to identify which receptors are modulated
by flavanols and to what extent this occurs.
There is now good evidence that the acute benefits for
cognitive function and blood flow exerted by cocoa flavanol
consumption peak approximately 90–120 min post-
consumption (Schroeter et al. 2006; Francis et al. 2006;
Scholey et al. 2010; Field et al. 2011); however, it is presently
unclear whether separate chronic mechanisms exists follow-
ing cumulative consumption over several weeks and months,
or indeed whether chronic consumption enhances the effec-
tiveness of acute mechanisms in a cumulative fashion. Despite
several plausible mechanisms for increased neuronal activity
(as described above), it remains to be seen whether a single
cocoa flavanol dose-induced increase in CBF is associated
with concomitant benefits in cognitive performance in the
immediate postprandial period. More broadly, recent reviews
of acute interventions and epidemiological surveys provide
good evidence that flavonoids and their subclasses are bene-
ficial for cognitive function (Macready et al. 2009; Lamport
et al. 2012; Scholey and Owen 2013). Investigations of CBF
and behavioural effects should also be extended to other
flavanol-rich foods and beverages (e.g. tea, grapes and ap-
ples). For example, consumption of apples containing
180mg epicatechin and 184 mg quercetin glycosides has been
shown to acutely augment nitric oxide status (Bondonno et al.
2014), a potential mechanism by which flavanols may lead to
increased CBF; however, there were no effects on behavioural
outcomes. Increased neuronal activation has also been ob-
served acutely using electroencephalogrammeasurements fol-
lowing a 300-mg epigallocatechin gallate dose (commonly
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found in tea; Scholey et al. 2012). In relation to this, future
studies should consider the effects of habitual flavonoid intake
since it is possible that benefits following an acute or chronic
intervention will only be observed when habitual intake is
low, although this was not considered presently.
In conclusion, the present findings support the hypothesis
that flavanol-rich cocoa beverages are associated with in-
creased CBF within a 2-h post-prandial time frame. More
specifically, increased brain perfusion following the HF drink
relative to the LF drink was observed in the anterior cingulate
cortex and a region in the left parietal lobe. These data add to
the substantial body of literature demonstrating that flavanol
consumption is beneficial for peripheral and cerebral vascular
function and thus for maintaining, protecting and enhancing
cardiovascular health.
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